These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 9773125

  • 1. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R, Madonna O, Brisac AM, Benetos A, Laurent S.
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison of angiotensin receptor antagonists and angiotensin converting enzyme inhibitors in arterial hypertension].
    Krezsinski JM, Sternon J.
    Rev Med Brux; 2000 Jun; 21(3):170-7. PubMed ID: 10925600
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-II receptor antagonists: a new class of antihypertensive agents.
    Weir MR.
    Am Fam Physician; 1996 Feb 01; 53(2):589-94. PubMed ID: 8629540
    [Abstract] [Full Text] [Related]

  • 11. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S.
    Acta Med Indones; 2008 Jan 01; 40(1):34-7. PubMed ID: 19054878
    [Abstract] [Full Text] [Related]

  • 12. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK, Sodhi RK, Singh M.
    Life Sci; 2007 Aug 02; 81(8):615-39. PubMed ID: 17692338
    [Abstract] [Full Text] [Related]

  • 13. New therapeutic prospects of renin-angiotensin system inhibition.
    Corvol P.
    Clin Exp Hypertens A; 1989 Aug 02; 11 Suppl 2():463-70. PubMed ID: 2691125
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The clinical pharmacology of angiotensin II antagonists].
    Arabidze GG, Novikova LS.
    Farmakol Toksikol; 1990 Aug 02; 53(2):80-6. PubMed ID: 2369961
    [Abstract] [Full Text] [Related]

  • 16. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S, Unger T.
    Drugs; 2002 Aug 02; 62 Spec No 1():43-52. PubMed ID: 12036388
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin receptor blockers: pharmacology and clinical significance.
    Mimran A, Ribstein J.
    J Am Soc Nephrol; 1999 Apr 02; 10 Suppl 12():S273-7. PubMed ID: 10201882
    [Abstract] [Full Text] [Related]

  • 18. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE, Julius S.
    Am Heart J; 2004 Nov 02; 148(5):747-54. PubMed ID: 15523303
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin receptor antagonists and ACE inhibitors.
    Howes LG, Christie N.
    Aust Fam Physician; 1998 Oct 02; 27(10):914-7, 919-21. PubMed ID: 9798290
    [Abstract] [Full Text] [Related]

  • 20. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS, Christensen S.
    Ugeskr Laeger; 2001 Dec 10; 163(50):7036-9. PubMed ID: 11794033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.